PureTech Health plc - American Depositary Shares —— 资产负债表 (NASDAQ:PRTC) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 989.99 M946.01 M702.65 M693.97 M602.63 M534.71 M 负债总额 336.45 M361.86 M155.06 M235.74 M194.7 M229.03 M 权益总额 653.54 M584.15 M547.59 M458.23 M407.93 M305.68 M 负债及股东权益总额 989.99 M946.01 M702.65 M693.97 M602.63 M534.71 M 总债务 —————— 净债务 ——————

PureTech Health plc - American Depositary Shares

PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.

新闻

Deupirfenidone获得罕见肺病孤儿药资格

Deupirfenidone receives orphan drug status for rare lung disease

PureTech的deupirfenidone获得FDA和欧盟治疗特发性肺纤维化孤儿药资格

PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF

PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PureTech CEO to present at J.P. Morgan Healthcare Conference

PureTech Health任命Robert Lyne为永久首席执行官

PureTech Health appoints Robert Lyne as permanent CEO

PureTech在股东担忧后提供股东大会结果更新

PureTech provides update on AGM results following shareholder concerns

PureTech股价在FDA关于IPF药物会议后下跌

PureTech stock falls after FDA meeting on IPF drug